Rite Aid Corp (RAD)
$9.68 0.26 (2.62%)
18:30 EST RAD Stock Quote Delayed 15 Minutes
Previous Close $4.44
Market Cap 10.33B
PE Ratio -28.47
Volume (Avg. Vol.) 1.49M
Day's Range 9.37 - 9.93
52-Week Range 0.43 - 11.58
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
Wednesday's 3 big stock charts highlight recent market winners whose rallies may be petering out.
By Ian Cooper
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.
Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.
Alphabet saved FIT stock with a big buyout, and these five stocks to buy could be next to be saved by an acquisition.
These eight penny stocks have gone from winners to losers, and while some of them could go back to being winners, not all of them will.
RAD stock both rallied by 50% and dropped by 30% in September - and none of it had anything to do with the fundamentals of Rite Aid stock, which remain bad.
Rite Aid stock – don’t wait for any management-led turnaround. This pharmacy retailer is laden with debt, cash flow losses and no clear turnaround plan.
Rather than trying desperately to find a buyer, Rite Aid will leverage their core strengths to bring value-add to their business. This is probably the best play available for Rite Aid stock.
By Thomas Niel
With this in mind, the stock is a hard pass. Investors likely can find more solid turnaround plays elsewhere. Given the volatility in the RAD stock prices, shares could shoot higher on speculation. But long term, Rite Aid stock is not a strong investment opportunity.
Rite Aid (NYSE:RAD) jumped more than 20% last week after exceeding second-quarter earnings guidance. The boost came at a good time. Rite Aid stock has....
Rite Aid (RAD) earnings for the second quarter of fiscal 2020 have RAD stock taking off on Thursday on a strong EPS beat.
With Rite Aid reporting Q2 earnings on Thursday, all eyes will focus on the pharmacy retailer’s forward guidance. Unfortunately, that might not be a good thing for RAD stock.
Rite Aid stock has a chance of recovering but the new CEO has plenty of work ahead. The company must grow prescription volumes and sales.
It was a slow session in the stock market today, with little gains showing up on Monday. Here's what happened in the U.S. stock market.
RAD stock looks tempting here in the midst of this lull, but what Rite Aid needs to do the most is the one thing that will be toughest to do.
With the RAD stock price down 95%, value investors might be intrigued. But there are better risk-adjusted plays than Rite Aid stock.
As with most investments, the future of Rite Aid stock depends on millennials. Here, new Rite Aid CEO Heyward Donigan has both an opportunity as well as significant risks.
Despite its cheap price, Rite Aid stock is hardly what you would call a discount. Instead, it’s a junk equity that you should steer clear from, considering that it doesn’t have an Amazon Counter-like catalyst in the foreseeable future.
From Market News Video
Investors in Rite Aid Corp (RAD) saw new options become available today, for the July 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!